Mount Sinai has developed a machine learning model forecasting the cardiovascular risk impact of CPAP in obstructive sleep apnea patients.
Key Details
- 1Mount Sinai team used machine learning to analyze data from over 2,600 patients in the SAVE trial.
- 2The model estimates whether CPAP usage will benefit or harm individual cardiovascular risk profiles.
- 3Substantial differences in treatment response were discovered across patient subgroups, with up to 100-fold differences in outcomes.
- 4Model is based on 23 selected baseline predictors from over 100 sleep and health variables.
- 5Findings highlight potential for precision medicine in treating sleep apnea and associated cardiovascular risks.
Why It Matters
This study marks a step towards personalized medicine using AI, supporting tailored treatment plans in sleep medicine and cardiovascular disease. The approach underscores the value of advanced analytics in stratifying risk and improving patient outcomes, reflecting broader trends toward individualized AI-powered decision support in clinical settings.
Source
EurekAlert
Related News
•EurekAlert
AI Framework Adapts Smartphone Audio for Pediatric Lung Sound Screening
Researchers developed a domain-adaptive deep learning model enabling smartphones to detect abnormal lung sounds in children for remote screening.
•EurekAlert
HKU Launches Centre for Health AI Research and Translation
The University of Hong Kong has established the Centre for Health AI Research and Translation (CHART) to drive trustworthy, patient-centered AI innovation in healthcare.
•EurekAlert
Holographic Neural Network Achieves Multi-Task AI via Light-Based Computing
Researchers have developed a holographic neural network using optics to perform multiple AI classification tasks simultaneously without hardware reconfiguration.